Making science work for development

Priorities for combating antimicrobial resistance

6 July

Delegates will discuss the implementation of recommendations in the independent review on AMR and the UK Government’s response, and incorporation into the UK Government’s current 5-year Antimicrobial Resistance strategy.

Taking part as a keynote speaker is Lord O’Neill of Gatley, Chair, Review on Antimicrobial Resistance and Visiting Research Fellow, Bruegel.

They will also assess the funding challenge for industry - with £50m set aside for a Global AMR Innovation Fund - and consider the priorities for healthcare commissioners, providers and clinicians to tackle antimicrobial resistance, following the launch of NHS England’s national AMR programme.

Overall, areas for discussion include:

  • Dealing with the financial cost of tackling antimicrobial resistance;
  • Challenges for researching and developing new antibiotics: collaboration, diagnostics and technology;
  • Progress in reducing the overprescribing of medicines and broad-spectrum antibiotics - following the publication of Public Health England’s ESPAUR report;
  • Impact of guidelines, workforce engagement and commissioning frameworks on antimicrobial stewardship and infection control; and
  • Raising awareness about the potential impact of antimicrobial resistance amongst patients and the public.